120 related articles for article (PubMed ID: 35931023)
1. Retraction Notice to: Allosteric Activators of Protein Phosphatase 2A Display Broad Antitumor Activity Mediated by Dephosphorylation of MYBL2.
Morita K; He S; Nowak RP; Wang J; Zimmerman MW; Fu C; Durbin AD; Martel MW; Prutsch N; Gray NS; Fischer ES; Look AT
Cell; 2022 Aug; 185(16):3058. PubMed ID: 35931023
[No Abstract] [Full Text] [Related]
2. Dephosphorylation of cdc25-C by a type-2A protein phosphatase: specific regulation during the cell cycle in Xenopus egg extracts.
Clarke PR; Hoffmann I; Draetta G; Karsenti E
Mol Biol Cell; 1993 Apr; 4(4):397-411. PubMed ID: 8389619
[TBL] [Abstract][Full Text] [Related]
3. Perphenazine exerts antitumor effects on HUT78 cells through Akt dephosphorylation by protein phosphatase 2A.
Tsuji S; Kohyanagi N; Mizuno T; Ohama T; Sato K
Oncol Lett; 2021 Feb; 21(2):113. PubMed ID: 33376545
[TBL] [Abstract][Full Text] [Related]
4. Regulation of rhodopsin dephosphorylation by arrestin.
Palczewski K; McDowell JH; Jakes S; Ingebritsen TS; Hargrave PA
J Biol Chem; 1989 Sep; 264(27):15770-3. PubMed ID: 2550422
[TBL] [Abstract][Full Text] [Related]
5. Dephosphorylation of major sperm protein (MSP) fiber protein 3 by protein phosphatase 2A during cell body retraction in the MSP-based amoeboid motility of Ascaris sperm.
Yi K; Wang X; Emmett MR; Marshall AG; Stewart M; Roberts TM
Mol Biol Cell; 2009 Jul; 20(14):3200-8. PubMed ID: 19458186
[TBL] [Abstract][Full Text] [Related]
6. Dephosphorylation of abnormal sites of tau factor by protein phosphatases and its implication for Alzheimer's disease.
Ono T; Yamamoto H; Tashima K; Nakashima H; Okumura E; Yamada K; Hisanaga S; Kishimoto T; Miyakawa T; Miyamoto E
Neurochem Int; 1995 Mar; 26(3):205-15. PubMed ID: 7787767
[TBL] [Abstract][Full Text] [Related]
7. Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A.
Gong CX; Grundke-Iqbal I; Iqbal K
Neuroscience; 1994 Aug; 61(4):765-72. PubMed ID: 7838376
[TBL] [Abstract][Full Text] [Related]
8. Dopamine transporters are dephosphorylated in striatal homogenates and in vitro by protein phosphatase 1.
Foster JD; Pananusorn B; Cervinski MA; Holden HE; Vaughan RA
Brain Res Mol Brain Res; 2003 Jan; 110(1):100-8. PubMed ID: 12573538
[TBL] [Abstract][Full Text] [Related]
9. Oxytocin alters the morphology of hypothalamic neurons via the transcription factor myocyte enhancer factor 2A (MEF-2A).
Meyer M; Berger I; Winter J; Jurek B
Mol Cell Endocrinol; 2018 Dec; 477():156-162. PubMed ID: 29928931
[TBL] [Abstract][Full Text] [Related]
10. Protein phosphatase 2A-B55β mediated mitochondrial p-GPX4 dephosphorylation promoted sorafenib-induced ferroptosis in hepatocellular carcinoma via regulating p53 retrograde signaling.
Qian B; Che L; Du ZB; Guo NJ; Wu XM; Yang L; Zheng ZX; Gao YL; Wang MZ; Chen XX; Xu L; Zhou ZJ; Lin YC; Lin ZN
Theranostics; 2023; 13(12):4288-4302. PubMed ID: 37554285
[No Abstract] [Full Text] [Related]
11. Dephosphorylation of Ser-137 in DARPP-32 by protein phosphatases 2A and 2C: different roles in vitro and in striatonigral neurons.
Desdouits F; Siciliano JC; Nairn AC; Greengard P; Girault JA
Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):211-6. PubMed ID: 9461512
[TBL] [Abstract][Full Text] [Related]
12. Monotherapy efficacy of blood-brain barrier permeable small molecule reactivators of protein phosphatase 2A in glioblastoma.
Merisaari J; Denisova OV; Doroszko M; Le Joncour V; Johansson P; Leenders WPJ; Kastrinsky DB; Zaware N; Narla G; Laakkonen P; Nelander S; Ohlmeyer M; Westermarck J
Brain Commun; 2020; 2(1):fcaa002. PubMed ID: 32954276
[TBL] [Abstract][Full Text] [Related]
13. Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53.
Calvisi DF; Simile MM; Ladu S; Frau M; Evert M; Tomasi ML; Demartis MI; Daino L; Seddaiu MA; Brozzetti S; Feo F; Pascale RM
Hepatology; 2011 Apr; 53(4):1226-36. PubMed ID: 21480327
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine hydroxylase dephosphorylation by protein phosphatase 2A in bovine adrenal chromaffin cells.
Leal RB; Sim AT; Gonçalves CA; Dunkley PR
Neurochem Res; 2002 Mar; 27(3):207-13. PubMed ID: 11958518
[TBL] [Abstract][Full Text] [Related]
15. Dephosphorylation of protein kinase C substrates, neurogranin, neuromodulin, and MARCKS, by calcineurin and protein phosphatases 1 and 2A.
Seki K; Chen HC; Huang KP
Arch Biochem Biophys; 1995 Feb; 316(2):673-9. PubMed ID: 7864622
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of a novel xylulose 5-phosphate-activated protein phosphatase catalyzing dephosphorylation of fructose-6-phosphate,2-kinase:fructose-2,6-bisphosphatase.
Nishimura M; Uyeda K
J Biol Chem; 1995 Nov; 270(44):26341-6. PubMed ID: 7592845
[TBL] [Abstract][Full Text] [Related]
17. The protein phosphatases involved in cellular regulation. 1. Modulation of protein phosphatases-1 and 2A by histone H1, protamine, polylysine and heparin.
Pelech S; Cohen P
Eur J Biochem; 1985 Apr; 148(2):245-51. PubMed ID: 2985384
[TBL] [Abstract][Full Text] [Related]
18. MYBL2 guides autophagy suppressor VDAC2 in the developing ovary to inhibit autophagy through a complex of VDAC2-BECN1-BCL2L1 in mammals.
Yuan J; Zhang Y; Sheng Y; Fu X; Cheng H; Zhou R
Autophagy; 2015; 11(7):1081-98. PubMed ID: 26060891
[TBL] [Abstract][Full Text] [Related]
19. Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma.
Zhang X; Lv QL; Huang YT; Zhang LH; Zhou HH
J Exp Clin Cancer Res; 2017 Aug; 36(1):105. PubMed ID: 28784180
[TBL] [Abstract][Full Text] [Related]
20. Cancerous inhibitor of protein phosphatase 2A determines bortezomib-induced apoptosis in leukemia cells.
Liu CY; Shiau CW; Kuo HY; Huang HP; Chen MH; Tzeng CH; Chen KF
Haematologica; 2013 May; 98(5):729-38. PubMed ID: 22983581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
